Perspective Therapeutics (CATX) Change in Accured Expenses (2010 - 2026)

Perspective Therapeutics has reported Change in Accured Expenses for 17 years, with the latest figure at -$3.6 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 40.8% year-over-year to -$3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $964000.0 (down 49.71% YoY) and the FY2025 annual result came in at $2.0 million, down 44.14% from the prior year.
• Change in Accured Expenses slipped to -$3.6 million in Q1 2026 per CATX's latest filing, from $1.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $5.5 million in Q3 2025 and troughed at -$3.6 million in Q1 2026.
• A 5-year average of $337176.5 and a median of $17000.0 in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses plunged 3700.0% in 2022, then soared 5958.82% in 2023.
• Over 5 years, Change in Accured Expenses stood at $573000.0 in 2022, then jumped by 293.72% to $2.3 million in 2023, then soared by 42.38% to $3.2 million in 2024, then slumped by 68.31% to $1.0 million in 2025, then slumped by 454.91% to -$3.6 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$3.6 million, $1.0 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.